No Established Medications for Auditory Hypersensitivity in Autism
There are currently no FDA-approved or guideline-recommended medications specifically targeting auditory hypersensitivity or noise annoyance in autism spectrum disorder, including frequency-specific triggers. The available evidence indicates that pharmacotherapy in ASD is reserved for specific behavioral symptoms and comorbid conditions, not sensory processing abnormalities 1.
Current Guideline Framework
The American Academy of Child and Adolescent Psychiatry guidelines explicitly state that pharmacotherapy should only be offered when there is a specific target symptom or comorbid condition 1. The recognized targets for medication include:
- Irritability and aggression
- Self-injurious behavior
- Hyperactivity and inattention
- Anxiety and depression
- Sleep disturbances
- Compulsive-like behaviors
Sensory hypersensitivity, including auditory issues, is notably absent from this list 1. The British Association for Psychopharmacology consensus guidelines similarly do not recommend routine pharmacological treatment for core ASD symptoms, which would include sensory processing abnormalities 2.
Critical Caveat: Risperidone May Worsen Hyperacusis
A significant concern is that risperidone—one of the few FDA-approved medications for irritability in ASD—can actually worsen auditory hypersensitivity. A documented case report describes an 11-year-old boy with autism whose hyperacusis worsened with risperidone, improved after discontinuation, and recurred upon re-challenge 3. This suggests that commonly prescribed ASD medications may paradoxically exacerbate the very sensory issues you're asking about.
Non-Pharmacological Approaches Show Promise
While medications lack evidence, white noise exposure has demonstrated positive effects in recent research 4. A 2025 study of 54 patients (ages 7-17) with ASD showed significant improvement in self-regulation, reduced motor restlessness, and increased attention span with white noise exposure (p < 0.001). Interestingly, patients with ASD plus intellectual disability tolerated white noise better and had longer exposure times 4.
Research Insights on Mechanisms
Animal model research suggests that noise hypersensitivity in ASD involves both automatic sensory filtering (thalamic mechanisms) and executive/goal-directed filtering (prefrontal mechanisms) 5. A combinatorial pharmacological approach targeting both circuits was required to fully normalize noise hypersensitivity in the Ptchd1 deletion mouse model 5. However, this remains experimental and has not translated to human clinical practice.
Practical Clinical Approach
Given the absence of effective medications:
- Avoid risperidone if auditory hypersensitivity is a primary concern, as it may worsen symptoms 3
- Consider environmental modifications first: noise-canceling headphones, quiet spaces, predictable sound environments
- Trial white noise exposure as a non-pharmacological intervention with emerging evidence 4
- Address comorbid anxiety or irritability that may be triggered by noise exposure, using standard ASD pharmacotherapy only if these secondary symptoms significantly impair function 1, 2
The hyperacusis literature confirms this is a prevalent but poorly understood phenomenon in ASD, with treatment knowledge still "growing and changing" 6. The condition involves complex neural networks beyond the auditory system, including regions involved in emotions, memory, and stress 7, making simple pharmacological solutions unlikely.